Preliminary data from a 4-year mirror-image and multicentre study of patients initiating paliperidone palmitate 6-monthly long-acting injectable antipsychotic: the Paliperidone 2 per Year study.
Saved in:
| Title: | Preliminary data from a 4-year mirror-image and multicentre study of patients initiating paliperidone palmitate 6-monthly long-acting injectable antipsychotic: the Paliperidone 2 per Year study. |
|---|---|
| Authors: | García-Carmona JA; Department of Neurology, Santa Lucía University Hospital, C/Mezquita s/n 30202, Cartagena, Murcia 30202, Spain.; Group of Clinical and Experimental Pharmacology, Institute for Biomedical Research of Murcia (IMIB), Murcia, Spain.; Faculty of Pharmacy and Nutrition, San Antonio Catholic University of Murcia (UCAM), Murcia, Spain., García-Pérez A; Centre of Mental Health Molina de Segura, Molina de Segura, Murcia, Spain., Isidro García G; Department of Psychiatry, Marqués de Valdecilla University Hospital, Universidad de Cantabria, Santander, Spain.; Psychiatry and Mental Health Research Group, Instituto Investigación Sanitaria Valdecilla (IDIVAL), Santander, Spain., Forcen-Muñoz LA; Centre of Mental Health Lorca, Lorca, Murcia, Spain., Ovejero García S; Fundación Jiménez Díaz University Hospital, Madrid, Spain., Sáez Povedano R; Department of Psychiatry, General Hospital of Villarrobledo, Villarrobledo, Albacete, Spain., González-Galdámez AL; Department of Psychiatry, Los Arcos-Mar Menor University Hospital, San Javier, Murcia, Spain., Mata Iturralde L; Fundación Jiménez Díaz University Hospital, Madrid, Spain., Hernández-Sánchez F; Centre of Mental Health Lorca, Lorca, Murcia, Spain., Ramirez Bonilla M; Department of Psychiatry, Marqués de Valdecilla University Hospital, Universidad de Cantabria, Santander, Spain.; Psychiatry and Mental Health Research Group, Instituto Investigación Sanitaria Valdecilla (IDIVAL), Santander, Spain., Fuentes-Pérez P; Psychiatry and Mental Health Research Group, Instituto Investigación Sanitaria Valdecilla (IDIVAL), Santander, Spain., Ovejas-Catalán C; Psychiatry and Mental Health Research Group, Instituto Investigación Sanitaria Valdecilla (IDIVAL), Santander, Spain., Suárez-Pinilla P; Department of Psychiatry, Marqués de Valdecilla University Hospital, Universidad de Cantabria, Santander, Spain.; Psychiatry and Mental Health Research Group, Instituto Investigación Sanitaria Valdecilla (IDIVAL), Santander, Spain., Valdivia-Muñoz F; Department of Psychiatry, Santa Lucía University Hospital, Cartagena, Murcia, Spain.; Unit of Assertive Community Treatment, Centre Mental Health Cartagena, Cartagena, Murcia, Spain., Fernández Abascal B; Department of Psychiatry, Marqués de Valdecilla University Hospital, Universidad de Cantabria, Santander, Spain.; Psychiatry and Mental Health Research Group, Instituto Investigación Sanitaria Valdecilla (IDIVAL), Santander, Spain., Omaña Colmenares M; Department of Psychiatry, Alcanyis General Hospital, Xátiva, Valencia, Spain., de Lourdes Martín-Pérez Á; Department of Psychiatry, Santa Lucía University Hospital, Cartagena, Murcia, Spain., Campos-Navarro MP; Department of Psychiatry, Santa Lucía University Hospital, Cartagena, Murcia, Spain., Baca-García E; Fundación Jiménez Díaz University Hospital, Madrid, Spain., Benavente-López S; Department Psychiatry, Infanta Elena University Hospital, Madrid, Spain., Raya Platero A; Department of Psychiatry, San Cecilio Clinic Hospital, Granada, Spain., Barberán Navalón M; Department of Psychiatry, Alcanyis General Hospital, Xátiva, Valencia, Spain., Sánchez-Alonso S; Fundación Jiménez Díaz University Hospital, Madrid, Spain., Vázquez-Bourgon J; Department of Psychiatry, Marqués de Valdecilla University Hospital, Universidad de Cantabria, Santander, Spain.; Psychiatry and Mental Health Research Group, Instituto Investigación Sanitaria Valdecilla (IDIVAL), Santander, Spain.; Centro de Investigación Biomédica en Red en Salud Mental (CIBERSAM), Instituto de Salud Carlos III, Sevilla, Spain., Pappa S; West London National Health System (NHS) Trust, London, UK.; Department of Brain Sciences, Imperial College of London, London, UK. |
| Source: | Therapeutic advances in psychopharmacology [Ther Adv Psychopharmacol] 2023 Dec 26; Vol. 13, pp. 20451253231220907. Date of Electronic Publication: 2023 Dec 26 (Print Publication: 2023). |
| Publication Type: | Journal Article |
| Journal Info: | Publisher: Sage Country of Publication: England NLM ID: 101555693 Publication Model: eCollection Cited Medium: Print ISSN: 2045-1253 (Print) Linking ISSN: 20451253 NLM ISO Abbreviation: Ther Adv Psychopharmacol Subsets: PubMed not MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| ISSN: | 2045-1253 |
|---|---|
| DOI: | 10.1177/20451253231220907 |
